Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarction
- 1 April 1987
- journal article
- Published by Elsevier BV in Thrombosis Research
- Vol. 46 (1), 109-120
- https://doi.org/10.1016/0049-3848(87)90211-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysisJournal of the American College of Cardiology, 1986
- Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exerciseThrombosis Research, 1985
- Fibrinopeptide A: a marker of acute coronary thrombosis.Circulation, 1985
- Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.Circulation, 1984
- Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction.Circulation, 1984
- A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarctionThe American Journal of Cardiology, 1984
- Fibrinolytic Activity in Men with Acute Myocardial Infarction before 60 Years of AgeActa Medica Scandinavica, 1983
- Disordered “fibrinolytic potential” in coronary heart diseaseThrombosis Research, 1977
- Fibrinolytic capacity of arm and leg veins after femoral shaft fracture and acute myocardial infarction.BMJ, 1975
- FIBRINOLYTIC ACTIVITY AND CORONARY-ARTERY DISEASEThe Lancet, 1968